Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition
- PMID: 39837324
- PMCID: PMC11925689
- DOI: 10.1016/j.neuron.2024.12.026
Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition
Abstract
Gliomas are aggressive neoplasms that diffusely infiltrate the brain and cause neurological symptoms, including cognitive deficits and seizures. Increased mTOR signaling has been implicated in glioma-induced neuronal hyperexcitability, but the molecular and functional consequences have not been identified. Here, we show three types of changes in tumor-associated neurons: (1) downregulation of transcripts encoding excitatory and inhibitory postsynaptic proteins and dendritic spine development and upregulation of cytoskeletal transcripts via neuron-specific profiling of ribosome-bound mRNA, (2) marked decreases in dendritic spine density via light and electron microscopy, and (3) progressive functional alterations leading to neuronal hyperexcitability via in vivo calcium imaging. A single acute dose of AZD8055, a combined mTORC1/2 inhibitor, reversed these tumor-induced changes. These findings reveal mTOR-driven pathological plasticity in neurons at the infiltrative margin of glioma and suggest new strategies for treating glioma-associated neurological symptoms.
Keywords: alterations in neuronal activity; brain tumor microenvironment; brain tumors; dendritic spines; excitatory neurons; glioma; glioma microenvironment; glioma-associated neuronal alterations; glioma-induced plasticity; mTOR inhibition; neuronal hyperexcitability.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors have declared no competing interests.
Update of
-
Glioma-Induced Alterations in Excitatory Neurons are Reversed by mTOR Inhibition.bioRxiv [Preprint]. 2024 Jan 21:2024.01.10.575092. doi: 10.1101/2024.01.10.575092. bioRxiv. 2024. Update in: Neuron. 2025 Mar 19;113(6):858-875.e10. doi: 10.1016/j.neuron.2024.12.026. PMID: 38293120 Free PMC article. Updated. Preprint.
References
-
- Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenite DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, and Heimans JJ (2003). Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54, 514–520. 10.1002/ana.10712. - DOI - PubMed
MeSH terms
Substances
Grants and funding
- R01 CA244780/CA/NCI NIH HHS/United States
- F30 CA257768/CA/NCI NIH HHS/United States
- R01 NS118513/NS/NINDS NIH HHS/United States
- R01 NS084142/NS/NINDS NIH HHS/United States
- R01 NS063226/NS/NINDS NIH HHS/United States
- T32 GM145440/GM/NIGMS NIH HHS/United States
- P30 CA013696/CA/NCI NIH HHS/United States
- U24 NS120055/NS/NINDS NIH HHS/United States
- R61 CA278402/CA/NCI NIH HHS/United States
- K08 NS116166/NS/NINDS NIH HHS/United States
- P30 CA196521/CA/NCI NIH HHS/United States
- U54 CA274504/CA/NCI NIH HHS/United States
- R03 NS090151/NS/NINDS NIH HHS/United States
- F30 CA288006/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
